4//SEC Filing
Gayko Urte 4
Accession 0001599298-22-000008
CIK 0001599298other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:07 PM ET
Size
8.0 KB
Accession
0001599298-22-000008
Insider Transaction Report
Form 4
Gayko Urte
Director
Transactions
- Award
Stock Option (right to buy)
2022-01-03+25,000→ 25,000 totalExercise: $2.82Exp: 2032-01-03→ Common Stock (25,000 underlying) - Award
Stock Option (right to buy)
2022-01-03$1.13/sh+42,553$48,085→ 67,553 totalExercise: $2.82Exp: 2032-01-03→ Common Stock (42,553 underlying)
Footnotes (4)
- [F1]The option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.
- [F2]Not applicable.
- [F3]The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.
- [F4]The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $48,000.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001559217
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:07 PM ET
- Size
- 8.0 KB